Prepayments (CK93) - Nykredit Realkredit A/S
To the Nasdaq Copenhagen
Prepayments (CK93)
Pursuant to s 24 of the Danish Capital Markets Act, Nykredit Realkredit A/S hereby publishes prepayment data (CK93) as at 23 December 2022 in the attached file.
Furthermore, the data will be distributed in the usual way through Nasdaq Copenhagen. Data on Nykredit and Totalkredit bonds is also available by ISIN code in Excel format on https://www.nykredit.com/en-gb/investor-relations/financial-reporting/prepayments/.
For further information about data format and contents, please refer to the Nasdaq website.
Questions may be addressed to Morten Bækmand Nielsen, Head of Investor Relations, tel +45 44 55 15 21.
Yours sincerely
Nykredit Realkredit A/S
Attachments
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About GlobeNewswire by notified
GlobeNewswire by notifiedGlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire by notified
Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire by notified
Ilkka Oyj – Acquisition of own shares on 27 March 202327.3.2023 18:00:00 CEST | Press release
ILKKA OYJ, STOCK EXCHANGE RELEASE, 27 March 2023 at 19:00 EET IlkkaOyj – Acquisition of own shares on 27 March 2023 At Nasdaq Helsinki Ltd: Date27 March 2023Exchange transactionBuyShare trading codeILKKA2Amount, shares 453Average price/share, EUR3.8044Total cost, EUR1,723.39 The company holds a total of 82,890 of its own shares (ILKKA2) including the shares acquired on 27 March 2023. Detailed information concerning the acquisition is attached to this stock exchange release. On behalf of Ilkka Oyj DANSKE BANK A/S, FINLAND BRANCH Jonathan Nyberg Antti Väliaho Additional information Olli Pirhonen, CEO, Ilkka Oyj, tel. +358 40 766 5418 www.ilkka.com Attachment Ilkka buyback 27.3.2023
Mendus announces request for conversion of convertible bonds by Negma Group27.3.2023 18:00:00 CEST | Press release
Mendus AB (“Mendus” publ; IMMU.ST), a biopharmaceutical company focused on immunotherapies addressing tumor recurrence, today announced that Negma Group (“Negma”) has by notice to Mendus requested the conversion of convertible bonds that have been issued to Negma in accordance with the financing agreement announced by Mendus through press releases on 26 August and 26 October 2022. Negma has requested conversion of six (6) convertible bonds issued on 3 January 2023, corresponding to SEK 150,000 of the convertible loan amounting to a total of SEK 5,425,000, into 127,118 shares. Upon registration at the Swedish Companies Registration Office, Mendus’ total share capital will amount to SEK 10,071,926.2 and the total number of shares and votes will amount to 201,438,524. The conversion price per share is SEK 1.18, equivalent to 92% of the second lowest closing volume weighted average share price (VWAP) of the 10 consecutive trading days preceding the issuance of conversion request by Negma.
Mendus tillkännager begäran från Negma Group om konvertering av konvertibla skuldebrev27.3.2023 18:00:00 CEST | Pressemelding
Mendus AB (“Mendus” publ; IMMU.ST), ett bioläkemedelsföretag fokuserat på immunterapier mot tumöråterfall, tillkännager idag att Negma Group (”Negma”) genom meddelande till Mendus har begärt konvertering av konvertibla skuldebrev som utfärdats till Negma i enlighet med det finansieringsavtal som Mendus tillkännagivit genom pressmeddelanden den 26 augusti och 26 oktober 2022. Negma har begärt konvertering av sex (6) konvertibla skuldebrev som emitterades den 3 januari 2023, motsvarande 150 000 kronor av det konvertibla lånet som uppgår till totalt 5 425 000 kronor, till 127 118 aktier. Efter registrering hos Bolagsverket kommer Mendus totala aktiekapital att uppgå till 10 071 926,2 kronor och det totala antalet aktier och röster kommer att uppgå till 201 438 524. Konverteringspriset per aktie är 1,18 kronor, motsvarande 92% av den näst lägsta dagliga volymvägda genomsnittliga aktiekursen (VWAP) under de 10 på varandra följande handelsdagarna före konverteringsbegäran från Negma. För ytt
Aspo Plc: Share Repurchase 27.3.202327.3.2023 17:30:00 CEST | Press release
Aspo PlcAnnouncement 27.3.2023Aspo Plc: Share Repurchase 27.3.2023In the Helsinki Stock ExchangeTrade date27.3.2023Bourse tradeBuyShareASPOAmount2,400SharesAverage price/ share8.4629EURTotal cost20,310.96EURAspo Plc now holds a total of 90 932 sharesincluding the shares repurchased on 27.3.2023On behalf of Aspo PlcNordea Bank OyjJanne SarvikiviSami HuttunenFurther information, please contact:Arto Meitsalo, CFO, Aspo Plc, tel. +358 40 5511 422, arto.meitsalo@aspo.comwww.aspo.com Attachment ASPO_27.3_trades
NGS Group AB: Offentliggör årsredovisning 202227.3.2023 17:30:00 CEST | Pressemelding
Härmed offentliggör NGS Group AB (publ) sin årsredovisning för 2022. Årsredovisningen finns även tillgänglig på bolagets hemsida www.ngsgroup.se. För att erhålla ett tryckt exemplar av årsredovisningen, vänligen kontakta bolaget via e-post på info@ngsgroup.se. För ytterligare information kontakta: Thomas Plate, tf CFO för NGS Group på telefon 076-894 9239 eller mailadress thomas.plate@ngsgroup.se. Denna information är sådan som NGS Group AB (publ) är skyldig att offentliggöra enligt lagen om värdepappersmarknaden, lagen om handel med finansiella instrument samt Nasdaq Stockholms regelverk. Informationen lämnades för offentliggörande den 27 mars 2023 kl. 17:30. Bilagor ngsgroupab-2022-12-31-svÅR NGS Group 2022